Dr. Allyson Brooks

Dr. Allyson Brooks, the Ginny Ueberroth Executive Medical Director at Hoag Women’s Health Institute, shares her insights on the transformation of menopause care. She discusses the impact of the FDA's recent removal of black box warnings on hormone therapy, empowering women to seek better care. Dr. Brooks highlights the importance of women's advocacy in reshaping midlife health and explains Hoag's innovative multidisciplinary approach to menopause management. Her vision includes personalized care plans and the creation of supportive communities for patients and clinicians alike.